
Bioanalytical Services
In Vitro Metabolism
The ADME assay development pipeline includes in vitro ADME assays that are necessary once a lead candidate has been selected. The safety profile of a drug candidate will depend partly on its interactions with other drugs, especially those that may be administered concomitantly in standard-of-care treatment. Assessing the risks of possible drug-interactions using validated bioanalytical methods is thus an essential early step in the candidate development process. IQVIA Laboratories offers a suite of in vitro assays to support drug-drug interaction testing, including cytochrome P450 (CYP) enzyme inhibition (IC50), time-dependent CYP inhibition, induction of CYP enzymes, and CYP reaction phenotyping. All in vitro metabolism assay results are presented in fully QC-reviewed, regulatory-style reports to support filing of IND applications.
Services
Related Services

ADME / DMPK Services
Learn more
Early Hit-to-Lead ADME Screening Bundle
Learn more
In Vitro Screening
Learn more
Discovery Bioanalysis
Learn more
High-Throughput ADME Services
Learn more
In Vitro Metabolism
Learn more
Assessing your Drug-Drug Interaction Testing Risk
Learn more
ADME Assays & Metabolite Profiling and Identification Services
Learn more
Metabolite Identification and Profiling
Learn more
Bioanalytical Services
Learn more
Small and Large Molecule LC-MS
Learn moreRelated Insights

Managing Informed Consent Samples from Clinical Trials
A set of best practices for the definition, tracking and management of allowable use attributes associated with samples collected in protocol based clinical trials

Biorepository and Specimen Management
Your biological specimens are irreplaceable assets – trust them with a proven partner

ADME Services
Accelerating your drug discovery, preclinical and clinical programs

IQVIA Laboratories Central Laboratory Services
Central laboratory solutions supporting clinical trials around the world

Helping you master your lab data
Improved oversight with your lab data now in full view

How COVID-19 Changed Clinical Trial Dynamics and Environment
Precision Medicine World Conference 2021 Virtual Presentation

Pediatric Initiative
Optimizing small blood volumes to prevent canceled tests in clinical trials for pediatric patients
Vaccine Laboratory Services
Test Menu

SARS-CoV-2 Vaccine Induced Antibody Profiles
Presented at World Vaccine Congress 2021

Approaches to demonstrating commutability of various NGS reference standards for targeted ctDNA analysis
Presented at the MCBIOS & MAQC 2021 Joint Conference